Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...

Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings ( Verano Holdings Stock Quote, Chart, News, Analysts, ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

ATB Capital Markets analyst Martin Toner has to maintained his “Outperform” rating and $210.00 price target on KXS.

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

In his May 6 corporate update, Goff said Propel’s revenue, EPS growth and ROE stand out among its fintech peers.

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...

ATB Capital Markets is sticking with its bullish view on Bitfarms, maintaining an Outperform rating and a $3.75 price target ...

In his May 7 corporate update, Leung remained bullish on Well Health’s positioning as a consolidator in Canada’s healthcare ...